This site is intended for UK Healthcare Professionals.
Contact Us | Cookies and Privacy Policy | Terms of and Conditions of Use | Sitemap | PIL | Pharmacovigilance Privacy Notice
Job code: AIR01/21 August 2021
PATIENT FRIENDLY DEVICE¹
The WockAIR® device is a dry powder inhaler (DPI) containing 60 doses in foil strip allowing for dose delivery assurance². It’s similar in design to other currently marketed inhaler devices in the UK which you and your patients might be familiar with.
DPIs do not require the same degree of coordination as pressurised metered dose inhalers (pMDIs) and so have been shown to be easier to use and less susceptible to user errors which can have a detrimental effect on drug delivery³
Key Device Features
1
2
3
4
5
6
1
Use of two colours helps distinguish the red protective cap from the white mouthpiece and lever arm.
2
Feedback window allows for visual inspection of the used blisters.
3
Serrations marked between used blisters makes tearing easier. Patients can check that they have taken both of their daily doses by removing the two used blisters each night.
4
Thumb grip demonstrates the side of the lever which should be lifted to prepare the next dose.
5
Dose counter shows how many doses are remaining. When this turns red it indicates there are ten or fewer doses remaining.
6
Colour used to differentiate between product strengths.
Device Delivery Assurance
How to use WockAIR®
For full information and guide on how to use the WockAIR® inhaler, please refer to the Patient information leaflet
Here’s a useful video that demonstrates how to use the device
Adverse events should be reported. Reporting forms and information can be found at: https://yellowcard.mhra.gov.uk/
Adverse events should also be reported to Wockhardt UK. Please contact us or email us at drug.safety@wockhardt.co.uk
REFERENCES
1. Virchow JC, Weuthen T, Harmer QJ, Jones S. Identifying the features of an easy-to-use and intuitive dry powder inhaler for asthma and chronic obstructive pulmonary disease therapy: results from a 28-day device handling study, and an airflow resistance study. Expert Opin Drug Deliv.
2. WockAIR® Summary of Product Characteristics
3. Ramadan W and Sarkis AT. Patterns of use of dry powder inhalers versus pressurized metered dose inhalers devices in adult patients with chronic obstructive pulmonary disease or asthma: An observational comparative study. Chronic Resp Dis 2017: 14(3); 309-320
*Forspiro® is a registered trade mark of Novartis AG